Loading
Latest filing published 30 Sept 2024 for Pressure Biosciences INC, €573.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Richard T. Schumacher on record concern Pressure Biosciences Inc, in the capacity of chief executive. We count 34 filings; the first trade dates from 22 November 2017 and the latest from 27 September 2024.
No open-market sale appears; the market trades are 6 purchases worth €5,269. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €573.
The latest filing, published on 30 September 2024, reports a transaction of €573 in Pressure Biosciences Inc. The most recent open-market purchase was published on 28 December 2018, 2,856 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations